LakeShore Biopharma Co Ltd (LSB)

Currency in USD
0.7300
-0.0900(-10.98%)
Closed·
After Hours
0.7034-0.0266(-3.64%)
·

LSB Financial Summary

Key Ratios

P/E Ratio-1.01
Price/Book0.17
Debt / Equity72.53%
Return on Equity-18.43%
Dividend Yield0.00%
EBITDA-12.93M
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2021
31/03
2022
31/03
2023
31/03
2024
31/03
2025
31/03
* In Millions of CNY (except for per share items)

Earnings

Latest Release
Aug 15, 2024
EPS / Forecast
-12.20 / -0.69
Revenue / Forecast
135.35M / 163.84M
EPS Revisions
Last 90 days

FAQ

What were LakeShore Biopharma's earnings for the latest quarter?

The LakeShore Biopharma EPS (TTM) is -5.22. LakeShore Biopharma reported sales of 135.35, net income of -181.17, and EPS of -12.20 for the latest quarter.

What was LakeShore Biopharma's net income for the latest quarter?

LakeShore Biopharma's net income for the latest quarter was -181.17.

How did LakeShore Biopharma's performance compare year-over-year in the latest quarter?

The company's revenue moved from 164.98 in the previous quarter to 135.35 in the latest quarter, and net income moved from -77.77 to -181.17 compared to the previous quarter.

What is LakeShore Biopharma's net profit margin on a TTM basis?

LakeShore Biopharma's trailing twelve months (TTM) net profit margin is -16.26%.

How does LakeShore Biopharma's debt to equity ratio compare to industry standards?

LakeShore Biopharma's total debt-to-equity ratio is 72.53%.

What is LakeShore Biopharma's return on investment on a TTM basis?

LakeShore Biopharma's trailing twelve months (TTM) return on investment (ROI) is -18.43%.

What were LakeShore Biopharma's total assets and liabilities in the latest quarter?

As of the latest quarter, LakeShore Biopharma reported total assets of 1,513.03 million and total liabilities of 802.23 million.

How has LakeShore Biopharma's total revenue grown this year?

LakeShore Biopharma's total revenue was 164.98 in the previous quarter and 135.35 in the latest quarter.

What is LakeShore Biopharma's gross margin on a TTM basis?

LakeShore Biopharma's trailing twelve months (TTM) gross margin is 82.47%.

What was LakeShore Biopharma's revenue per share for the latest quarter?

LakeShore Biopharma's revenue per share for the latest quarter was 43.98.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.